Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an estimate of the potential savings accruing to the public purse from reduced hospital admissions in the event that Orkambi were to be made available on the NHS.

The Department has made no estimate. Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of resources. In developing its guidance, NICE takes into account all the costs and savings associated with the treatment.